Results 261 to 270 of about 41,914,794 (278)

Clinical studies of topiramate

Drugs of Today, 1999
Topiramate had well-documented efficacy as an adjunctive agent for partial-onset seizures in 5 double-blind, parallel trials, reducing seizure frequency by 35-47% at 400 mg/day, the optimal dose for most patients. It can also be used as monotherapy for partial-onset seizures. A broad spectrum of action is suggested by studies showing efficacy against a
openaire   +2 more sources

Clinical studies with TNF

Biotherapy, 1991
T, Taguchi, Y, Sohmura
openaire   +2 more sources

Zolmitriptan clinical studies

Drugs of Today, 1998
Zolmitriptan, a selective 5-HT(1B/D) agonist was developed for the acute treatment of migraine. Dose-finding studies show a clearly defined dose response curve for the oral formulation with onset of efficacy demonstrated within 45 min of dosing. Clinical trials support its efficacy in all types of migraine, with excellent safety and tolerability in ...
openaire   +2 more sources

A CLINICAL STUDY OF HYDRAMNIOS

Obstetrical & Gynecological Survey, 1960
J C, BUCKINGHAM, T W, McELIN, V M, BOWERS, J, McVAY   +3 more
openaire   +2 more sources

CLINICAL STUDIES ON TERRAMYCIN

Annals of the New York Academy of Sciences, 1950
M, FINLAND, T M, GOCKE, G G, JACKSON, C R, WOMACK, E H, KASS   +4 more
openaire   +2 more sources

Clinical Orthopedic Studies

Clinical Orthopaedics and Related Research, 1968
openaire   +2 more sources

A CLINICAL STUDY OF LEUKONYCHIA.*

British Journal of Dermatology, 1953
openaire   +2 more sources

CLINICAL STUDIES WITH CHLORPROPAMIDE

Annals of the New York Academy of Sciences, 1959
openaire   +2 more sources

CLINICAL STUDIES WITH AUREOMYCIN

Annals of the New York Academy of Sciences, 1948
H S, COLLINS, T F, PAINE, M, FINLAND
openaire   +2 more sources

A Clinical Study of Cephalexin

The Journal of Clinical Pharmacology and New Drugs, 1973
openaire   +2 more sources